iifl-logo-icon 1
IIFL

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

  • Open Demat with exclusive Advice & Services
  • Get a dedicated Relationship Manager to help you grow your wealth
  • Exclusive advisory on 20+ trading & wealth-based investment options
  • One tap Investments, Automated trading & much more
  • Minimum 1 lakh margin required
sidebar image

Q3FY24 Review: KIMS: Broader story intact, barring the Q3 one-offs

6 Feb 2024 , 01:37 PM

KIMS’ Q3 Ebitda margin (down 265bps QoQ) was impacted by negative operating leverage from one-off factors such as election in TG, cyclone in AP, and incremental opex from refurbishment of existing hospitals & addition of M&C care in the Secunderabad hospital. Adjusted for these one-offs, analysts of IIFL Securities estimate margins would have been flat QoQ at ~26% in Q3. While analysts of IIFL Securities expect these oneoffs to normalize in Q4, KIMS remains on track to add 25% incremental bed capacities (1,000 beds) in FY25 across Nashik, Thane and Bangalore. These capacity expansions, along with 10/13% revenue Cagr in TG/AP hospitals and further margin improvement in Sunshine/Nagpur hospitals, should drive 18/21% overall revenue/Ebitda Cagr over FY24-27. Analysts of IIFL Securities downgrade FY25/26 Ebitda by 1-2% to factor-in the Q3 weakness. KIMS remains one of their preferred picks in the Healthcare space and their TP of Rs2,350 (at 23x FY26 Ebitda) implies 13% upside. 

TG/AP hospitals will likely clock 10/13% revenue Cagr over FY24-27, driven by ARPOB growth of 5-6% and KIMS’ plans to operationalize another 100-150 beds in both these clusters from existing capacities over the next few quarters. Focus is on adding Oncology/M&C care across TG/AP hospitals (M&C wing Cuddle was added in Secunderabad in Q3), which will help to improve case mix particularly in AP. While KIMS is operating at 61/72% occupancies (on operating beds) in TG/AP, mgmt sees peak occupancies of 80-85% over the next few yrs. 

Margin traction in Sunshine and Nagpur has been strong: 

Despite Sunshine’s revenue declining 14% QoQ in Q3 owing to relocation to the new Begumpet campus and key doctor being on leave, Sunshine’s Ebitda margin was largely steady at ~22% in Q3 vs ~23% in H1. Aided by rental savings, mgmt expects Sunshine’s margins to improve to 30% in FY25 vs 28.5% factored in analysts of IIFL Securities estimates. Nagpur hospital’s margin has also improved over the past 3 quarters from 6% to 13% to 17% and mgmt expects margins to reach 20-25% in FY25 vs 20% assumed in their estimates. 

25% bed capacities to be added in FY25, through commissioning of the Nashik hospital (300 beds) in May’24 and Thane (300)/Bangalore (415) hospitals in Q4FY25. KIMS expects doctors from smaller practices/organised competition to join them in Nashik. Mgmt is hopeful that Nashik hospital will achieve Ebitda breakeven within 12 months. If Thane funding is not completed by Feb’24, KIMS will proceed on its own.

Related Tags

  • KIMS
sidebar mobile

BLOGS AND PERSONAL FINANCE

Read More

Most Read News

Sensex and Nifty dip from record highs
19 Jun 2024|01:57 PM
Akme Fintrade IPO opens today
19 Jun 2024|01:47 PM
Zee announces Mukund Galgali as acting CFO
19 Jun 2024|01:32 PM
Read More
Knowledge Centerplus
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Securities Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Knowledge Centerplus

Follow us on

facebooktwitterrssyoutubeinstagramlinkedin

2024, IIFL Securities Ltd. All Rights Reserved

ATTENTION INVESTORS
  • Prevent Unauthorized Transactions in your demat / trading account Update your Mobile Number/ email Id with your stock broker / Depository Participant. Receive information of your transactions directly from Exchanges on your mobile / email at the end of day and alerts on your registered mobile for all debits and other important transactions in your demat account directly from NSDL/ CDSL on the same day." - Issued in the interest of investors.
  • KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
  • No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."

www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.

RISK DISCLOSURE ON DERIVATIVES
  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to Rs. 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Copyright © IIFL Securities Ltd. All rights Reserved.

Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248

plus
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.